Stereoselective synthesis and biological evaluation of ferrocene-containing 5-hydroxyeicosatetraenoic acid analogues

European Journal of Organic Chemistry

Volumn , Issue 24, 2011, Pages 4634-4644

  Kausch Busies, Nina ^a   Neudörfl, Jörg Martin ^a   Wefelmeier, Pascal ^b   Prokop, Aram ^b   Kühn, Hartmut ^c   Schmalz, Hans Günther ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Antitumor agents; Diastereoselectivity; Iron; Planar chiral ferrocenes; Titanium; Zinc

Indexed keywords

EID: 80051490261     PISSN: 1434193X     EISSN: 10990690     Source Type: Journal    
DOI: 10.1002/ejoc.201100003     Document Type: Article

References (72)

1. a) P. W. Collins, S. W. Djuric, Chem. Rev. 1999, 93, 1533-1564;
2. b) S. Das, S. Chandrasekhar, J. Yadav, R. Grée, Chem. Rev. 2007, 107, 3286-3337;
3. c) E. Mutschler, G. Geisslinger, H. K. Kroemer, P. Ruth, M. Schäfer-Korting, Arzneimittelwirkungen, Lehrbuch der Pharmakologie und Toxikologie, 9th ed., Wissenschaftliche Verlagsgesellschaft, Stuttgart, 2008.
4. See, for example: a) A. J. Pearson, Acc. Chem. Res. 1980, 13, 463-469;
5. b) R. Grée, J.-P. Lellouche, Adv. Met.-Org. Chem. 1995, 4, 129-273;
6. c) R. Grée, Synthesis 1989, 341-396.
7. An iron-containing natural product analogue is ferroquine (which is at clinical Phase II at Sanofi-Aventis): a) F. Dubar, J. Khalife, J. Brocard, D. Dive, C. Biot, Molecules 2008, 13, 2900-2907;
8. b) A. Kreidenweiss, P. G. Kremsner, K. Dietz, B. Mordmüller, Am. J. Trop. Med. Hyg. 2006, 75, 1178-1181;
9. c) C. Atteke, J. M. M. Ndong, A. Aubouy, L. Maciejewski, J. Brocard, J. Lébibi, P. Deloron, J. Antimicrob. Chemother. 2003, 51, 1021-1024;
10. d) C. Biot, G. Glorian, L. A. Maciejewski, J. S. Brocard, J. Med. Chem. 1997, 40, 3715-3718;
11. another example is the anti-cancer agent ferrocifen (which has an improved biological profile compared with tamoxifen, because it also attacks breast cancer cells, which are resistant to tamoxifen), see: e) S. Top, A. Vessieres, C. Cabestaing, I. Laios, G. Leclercq, C. Provot, G. Jaouen, J. Organomet. Chem. 2001, 637, 500-506;
12. f) S. Top, A. Vessieres, G. Leclercq, J. Quivy, J. Tang, J. Vaissermann, M. Huche, G. Jaouen, Chem. Eur. J. 2003, 9, 5223-5236;
13. g) G. Jaouen, S. Top, A. Vessieres, G. Leclercq, M. J. McGlinchey, Curr. Med. Chem. 2004, 11, 2505-2517;
14. h) E. Hillard, A. Vessieres, F. Le Bideau, D. Plazuk, D. Spera, M. Huche, G. Jaouen, ChemMedChem 2006, 1, 551-559;
15. i) E. Hillard, A. Vessieres, L. Thouin, G. Jaouen, A. Amatore, Angew. Chem. 2005, 118, 291-296;
16. Angew. Chem. Int. Ed. 2005, 45, 285-290;
17. j) A. Vessieres, S. Top, P. Pigeon, E. Hillard, L. Boubekeur, D. Spera, G. Jaouen, J. Med. Chem. 2005, 3937-3940;
18. k) A. Vessieres, D. Spera, S. Top, B. Misterkiewicz, J. M. Heldt, E. A. Hillard, M. Huche, M. A. Plamont, E. Napolitano, R. Fiaschi, G. Jaouen, ChemMedChem 2006, 1, 1275-1281;
19. For other recent examples of bio-relevant ferrocene derivatives, see: l) I. Tranchant, A.-C. Hervé, S. Carlisle, P. Lowe, C. J. Slevin, C. Forssten, J. Dilleen, A. B. Tabor, D. E. Williams, H. C. Hailes, Bioconjugate Chem. 2007, 18, 199-208;
20. m) M. Patra, G. Gasser, M. Wenzel, K. Merz, J. E. Bandow, N. Metzler-Nolte, Organometallics 2010, 29, 4312-4319.
21. For 1, 3-diene-Fe(CO)3 complexes of eicosanoid-related ligands, see:a) C. Tao, W. A. Donaldson, J. Org. Chem. 1993, 58, 2134-2143;
22. b) K. Nunn, P. Mosset, R. Grée, R. Saalfrank, Angew. Chem. 1988, 100, 1233-1234;
23. Angew. Chem. Int. Ed. Engl. 1988, 27, 1188-1189;
24. c) K. Nunn, P. Mosset, R. Grée, R. W. Saalfrank, J. Org. Chem. 1992, 57, 3359-3364;
25. d) P. Pinsard, J.-P. Lellouche, J.-P. Beaucourt, R. Grée, Tetrahedron Lett. 1990, 31, 1141-1142;
26. for reviews on the use of 1, 3-diene-Fe(CO) 3 complexes in eicosanoid synthesis, see: e) W. A. Donaldson, S. Chaudhury, Eur. J. Org. Chem. 2009, 3831-3843;
27. f) A. J. Pearson, Acc. Chem. Res. 1980, 13, 463-469;
28. g) R. Grée, J.-P. Lellouche, Adv. Met.-Org. Chem. 1995, 4, 129-273;
29. h) R. Grée, Synthesis 1989, 341-396;
30. for ferrocene-containing prostaglandin analogues, see: i) V. I. Sokolov, J. Organomet. Chem. 1983, 250, 439-446;
31. j) V. I. Sokolov, L. L. Troitskaya, N. S. Khrushcheva, O. A. Reutov, J. Organomet. Chem. 1989, 378, 227-233;
32. k) V. A. Kozinets, J. V. Chernyavskaya, F. A. Lakhvich, V. A. Korshun, D. T. Kozhich, A. A. Akhrem, Dokl. Akad. Nauk Belarusi 1994, 38, 56-58.
33. N. Kausch-Busies, J. M. Neudörfl, B. Kater, A. Prokop, H.-G. Schmalz, Eur. J. Org. Chem. 2011, accepted for publication.
34. We have shown that certain iron-containing nucleoside analogues exhibit pronounced apoptosis induction in tumor cells if a butadiene-Fe(CO)3 or a ferrocene substructure is present, see: a) H.-G. Schmalz, A. Prokop, T. Wieder, P. Daniel, PCT Int. Appl. WO 02/80923A1, 2002
35. [Chem. Abstr. 2002, 137, 295194;]
36. [AN 2002:793423];
37. b) D. Schlawe, A. Majdalani, J. Velcicky, E. Heßler, T. Wieder, A. Prokop, H.-G. Schmalz, Angew. Chem. 2004, 116, 1763-1766;
38. Angew. Chem. Int. Ed. 2004, 43, 1731-1734;
39. c) P. James, J. Neudörfl, M. Eißmann, P. Jesse, A. Prokop, H.-G. Schmalz, Org. Lett. 2006, 8, 2763-2766.
40. Cyclic analogues of hydroxyeicosatetraenoic acids have been prepared and studies by Gree and co-workers, see: a) A. Hachem, Y. Le Floc, R. Grée, C. Cerletti, Y. Rolland, S. Simonet, T. Verbeuren, Tetrahedron Lett. 2002, 43, 5221-5223;
41. b) A. Hachem, Y. Le Floc, R. Grée, Y. Rolland, S. Simonet, T. Verbeuren, Tetrahedron Lett. 2002, 43 5217-5219;
42. c) F. Caijo, P. Mosset, R. Grée, V. Audinot-Bouchez, J. Boutin, P. Renard, D.-H. Caignard, C. Dacquet, Eur. J. Org. Chem. 2006, 9, 2181-2196.
43. a) O. Riant, O. Samuel, T. Fleßner, S. Taudien, H. B. Kagan, J. Org. Chem. 1997, 62, 6733-6745;
44. For a recent review, see: b) V. Mamane, Tetrahedron: Asymmetry 2010, 21, 1019-1029.
45. The absolute configuration of the planar-chiral ferrocene substructure is specified according to the method of Schlögl [as (RP) or (RS)]. For details, see: K. Schlögl, Top. Stereochem. 1971, 1, 39.
46. Aromatic aldehydes often show unsatisfactory Z-selectivity in Wittig reactions, see: B. E. Marynoff, A. B. Reitz, Chem. Rev. 1989, 89, 863-927.
47. B. Ferber, S. Top, A. Vessières, R. Welter, G. Jaouen, Organometallics 2006, 25, 5730-5739.
48. Alkynes are a common substructure in eicosanoid analogues, see, for instance: a) E. J. Corey, S. S. Kantner, P. T. Lansbury Jr., Tetrahedron Lett. 1983, 24, 265-268;
49. b) E. J. Corey, J. E. Munroe, J. Am. Chem. Soc. 1982, 104, 1752-1754;
50. c) E. J. Corey, J. Kang, Tetrahedron Lett. 1982, 23, 1651-1654.
51. H. Lindlar, R. Dubuis, Org. Synth., Coll. Vol. 5 1973, 880-883.
52. C. A. Brown, V. K. Ahuja, J. Chem. Soc., Chem. Commun. 1973, 553-554.
53. B. L. Sondegam, G. Charles, T. M. Akam, Tetrahedron Lett. 1980, 21, 1069-1070.
54. a) H. C. Brown, G. Zweifel, J. Am. Chem. Soc. 1961, 83, 3834-3840;
55. b) H. C. Brown, G. A. Molander, J. Org. Chem. 1986, 51, 4512-4514;
56. E. Negishi, K. W. Chiu, J. Org. Chem. 1976, 41, 3484-3486.
57. N. Suzuki, Y. Kaneko, T. Tsukanaka, T. Nomoto, Y. Ayaguchi, Y. Izawa, Tetrahedron 1985, 41, 2387-2392.
58. a) C. J. Taylor, F. X. Roca, C. J. Richards, Synlett 2005, 2159-2161;
59. b) H. Li, H. Cheng, A. Seow, T. Loh, Tetrahedron Lett. 2007, 48, 2209-2211.
60. H. Ochiai, T. Nishihara, Y. Tamaru, Z. Yoshida, J. Org. Chem. 1988, 53, 1343-1344.
61. [6]] ) we had identified 2-Me-THF as a particularly useful solvent for the addition of the Zn-Ti reagent 14 to an aldehyde. For other uses of 2-Me-THF as a solvent, see: a) T. Robert, J. Velder, H.-G. Schmalz, Angew. Chem. 2008, 120, 7832-7835;
62. Angew. Chem. Int. Ed. 2008, 47, 7718-7721;
63. b) D. F. Aycock, Org. Process Res. Dev. 2007, 11, 156-159.
64. E. J. Corey, N. M. Weinshenker, T. K. Schaaf, W. Huber, J. Am. Chem. Soc. 1969, 91, 5675-5677;
65. E. J. Corey, T. K. Schaaf, W. Huber, V. Koelliker, N. M. Weinshenker, J. Am. Chem. Soc. 1970, 92, 397-398;
66. E. J. Corey, R. Noyori, T. K. Schaaf, J. Am. Chem. Soc. 1970, 92, 2586-2587.
67. G. W. Gokel, D. Marquarding, I. K. Ugi, J. Org. Chem. 1972, 37, 3052-3058.
68. T. Hundertmark, A. F. Littke, S. L. Buchwald, G. C. Fu, Org. Lett. 2000, 2, 1729-1731.
69. a) J. M. Dale, H. S. Mosher, J. Am. Chem. Soc. 1973, 95, 512-519;
70. b) J. M. Dale, D. L. Dull, H. S. Mosher, J. Org. Chem. 1969, 34, 2543-2549.
71. For excellent reviews, see: c) J. M. Seco, E. Quiñoá, R. Riguera, Chem. Rev. 2004, 104, 17-117;
72. J. M. Seco, E. Quiñoá, R. Riguera, Tetrahedron: Asymmetry 2001, 12, 2915-2925.